Table 3.
ART Adherence | Undetectable Viral Load | Percentage of CD4 Count | |||||||
---|---|---|---|---|---|---|---|---|---|
B | 95% CI | β | B | 95% CI | β | B | 95% CI | β | |
Age | 0.82 | −0.46 to 2.12 | 0.11 | 0.04 | −0.03 to 0.11 | 0.13 | 0.10 | −0.49 to 0.67 | 0.03 |
Gender (1 = female) | 8.05 | −4.05 to 19.53 | 0.13 | 0.00 | −0.57 to 0.57 | 0.00 | 2.89 | −2.08 to 8.11 | 0.11 |
Race (1 = White) | −0.17 | −16.41 to 15.65 | 0.00 | −0.41 | −1.15 to 0.33 | −0.11 | 1.17 | −5.39 to 8.07 | 0.03 |
Income (1 = US$30 000+) | 7.44 | −13.49 to 28.99 | 0.07 | −1.04 | −2.20 to 0.01 | −0.22 | 1.68 | −7.32 to 11.08 | 0.03 |
Years since HIV diagnosis | −0.19 | −0.99 to 0.58 | −0.04 | 0.01 | −0.03 to 0.05 | 0.05 | −0.33 | −0.67 to 0.01 | −0.17 |
HIV stigma | −0.36 | −1.29 to 0.63 | −0.08 | 0.04 | −0.01 to 0.08 | 0.19 | −0.51 | −0.92 to −0.09 | −0.26b |
Depressive symptoms | −0.06 | −1.10 to 0.99 | −0.01 | 0.00 | −0.06 to 0.05 | −0.02 | 0.15 | −0.31 to 0.61 | 0.07 |
Loneliness | 0.68 | −0.49 to 1.86 | 0.13 | −0.02 | −0.08 to 0.04 | −0.10 | 0.13 | −0.38 to 0.64 | 0.06 |
Alcohol use problems | −0.49 | −2.25 to 1.30 | −0.05 | −0.02 | −0.11 to 0.07 | −0.04 | 0.37 | −0.40 to 1.14 | 0.09 |
Drug use problems | 0.08 | −2.14 to 2.22 | 0.01 | 0.00 | −0.11 to 0.11 | 0.00 | −0.17 | −1.15 to 0.79 | −0.03 |
ART adherence | - | - | - | 0.02 | 0.01 to 0.03 | 0.40c | - | - | - |
Viral load (1 = undetectable) | - | - | - | - | - | - | 2.54 | 0.13 to 4.95 | 0.25b |
R 2 | 0.12c | 0.37c | 0.20c |
Abbreviations: ART, antiretroviral therapy; 95% CI, 95% credibility interval.
a N = 120. Analyses were conducted as simultaneous regressions using Bayes estimation. Undetectable viral load was treated as a binary variable with a logit link.
b P < .05.
c P < .001.